Hua Zhang
Other Government · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Unresectable Non-small Cell Lung Cancer | Phase 2 | 2024-08-27 |
| Completed | Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B Virus Hepatitis B Infection, Chronic Infection, Viremia | Phase 4 | 2009-03-01 |